MedTrace Logo

Von Willebrand Disease in the Netherlands

NCT03521583 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2020-08-17

No results posted yet for this study

Summary

The primary aim of this study is to prospectively investigate the current bleeding tendency of children and adults with VWD.

Conditions

  • Von Willebrand Disease

Sponsors & Collaborators

  • Stichting Haemophilia (Dutch Haemophilia Foundation)

    collaborator UNKNOWN

  • CSL Behring

    collaborator INDUSTRY

  • Shire

    collaborator INDUSTRY

  • Erasmus Medical Center

    lead OTHER

Principal Investigators

  • Frank WG Leebeek, MD, PhD · Erasmus Medical Center

  • Ferdows Atiq, MD · Erasmus Medical Center

  • Marjon H Cnossen, MD, PhD · Erasmus Medical Center

  • Karin Fijnvandraat, MD, PhD · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

  • Jeroen Eikenboom, MD, PhD · Leiden University Medical Center

  • Johanna G van der Bom, PhD · Leiden University Medical Center

  • Britta AP Laros-van Gorkom, MD, PhD · Radboud University Medical Center

  • Karina Meijer, MD, PhD · University Medical Center Groningen

  • Karin PM van Galen, MD, PhD · UMC Utrecht

  • Joke de Meris · Netherlands Hemophilia Society

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-28
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03521583 on ClinicalTrials.gov